INTERACTIONS OF HTLV-III WITH T4 CELLS
INTERACTIONS OF HTLV-III WITH T4 CELLS
批准号:
3546667
负责人:
James A Hoxie
金额:
$13.14万
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-04-01 至 1989-03-31
关键词:
AIDS antibody formation antibody specificity antiidiotype antibody autoantigens electron microscopy enzyme linked immunosorbent assay fluorescence microscopy gene expression helper T lymphocyte host organism interaction human immunodeficiency virus 1 human subject immunosuppression monoclonal antibody noncytopathogenic virus phorbols protein kinase scintillation counter surface antigens thin layer chromatography virus antigen virus cytopathogenic effect virus infection mechanism virus morphology virus replication virus virus interaction
中文摘要
艾滋病逆转录病毒(HTLV-III、LAV和ARV)已显示出对
选择性感染T淋巴细胞亚群
单抗OKT4或Leu-3a。这种专一性是通过
至少部分是由于病毒与所表达的T4抗原的关联
在这些细胞的表面。病毒上与之结合的结构
这种抗原,以及调节T4表达的细胞因子
病毒感染后的分子和影响细胞病变效应
仍有待确定。这项提案将调查
HTLV-III与T4细胞在三个区域。1)努力找出
与T4结合所需的病毒相关决定因素
淋巴细胞。初步观察表明,该病毒可能
在萌发过程中选择性地整合HLC II类(DR)决定因素
细胞表面。细胞来源的DR抗原可能是
病毒粒子在感染T4细胞期间的利用将进一步
调查过了。此外,抗T4的单抗可以抑制
病毒结合将被用于生产抗独特型作为一种策略
鉴定与T4结合的病毒粒子上的结构。2)因素
它调节T4抗原和细胞受体的表达
将对HTLV-III进行评估。这项建议将进一步探索
佛波酯调节T4的表达的研究结果
并降低T4细胞对HTLV-III感染的易感性。
病毒渗透/感染和病毒感染之间可能的相互作用
除了发现之外,还将对激活蛋白激酶C进行研究
佛波酯改变T4细胞系的能力
感染HTLV-III以支持病毒生产。3)最新发现
已经表明,除了细胞死亡外,艾滋病逆转录病毒还可能
产生一种无细胞毒性的、持续感染正常外周血的T4
淋巴细胞。这表明,一系列生物学后果可能
发生在HTLV-III感染之后。HTLV-III的细胞病变效应
感染将在T4细胞系中进行评估,这些细胞系对
抗原、同种异体抗原或有丝分裂原。将努力确定主机
影响感染后细胞毒性的因素和功能
当发生非细胞毒性感染时对T4细胞的影响。
英文摘要
The AIDs-retroviruses (HTLV-III, LAV, and ARV) have shown a tropism for
selectively infecting the T-lymphocyte subpopulation identified by the
monoclonal antibodies OKT4 or Leu-3a. This specificity is mediated at
least in part by the association of the virus with the T4 antigen expressed
on the surface of these cells. The structures on the virus which bind to
this antigen, and cellular factors which regulate the expression of the T4
molecule and influence cytopathic effects which follow viral infection
remain to be determined. This proposal will investigate the interaction of
HTLV-III with T4 cells in three areas. 1) Efforts will be made to identify
the viral-associated determinants which are required for binding to T4
lymphocytes. Preliminary observations have suggested that the virus may
selectively incorporate HLC class II (DR) determinants during budding from
the cell surface. The possibility that DR antigens of cellular origin are
utilized by the virion during infection of the T4 cell will be further
investigated. In addition, monoclonal anti-T4 antibodies which inhibit
viral binding will be used to produce anti-idiotypes as a strategy for
identifying the structures on the virion which bind to T4. 2) Factors
which regulate the expression of the T4 antigen and cellular receptors for
HTLV-III will be evaluated. This proposal will further explore the
findings that phorbol esters modulate both the expression of the T4
molecule and reduce the susceptability of T4 cells to HTLV-III infection.
Possible interactions between viral penetration/infection and the
activation protein kinase-C will be investigated, in addition to findings
that phorbol esters alter the ability of T4 cell lines which are stably
infected with HTLV-III to support viral production. 3) Recent findings
have indicated that in addition to cell death, AIDS retroviruses may also
produce a non-cytotoxic, persistent infection of normal peripheral blood T4
lymphocytes. This has suggested that a range of biological consequences may
occur following HTLV-III infection. Cytopathic effects of HTLV-III
infection will be evaluated in T4 cell lines specifically responsive to
antigen, alloantigen or mitogen. Efforts will be made to determine host
factors which influence cytotoxicity following infection, and functional
consequences for the T4 cell when non-cytotoxic infection occurs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeted interventions to reduce or eliminate the SIV reservoir in a novel model of elite control
-
批准号:10013657
-
项目类别:
-
资助金额:$85.02万
-
财政年份:2020
-
负责人:James A Hoxie
-
依托单位:
Targeted interventions to reduce or eliminate the SIV reservoir in a novel model of elite control
-
批准号:10371090
-
项目类别:
-
资助金额:$78.77万
-
财政年份:2020
-
负责人:James A Hoxie
-
依托单位:
Role of SIV and HIV Env cytoplasmic tail in pathogenesis and protective immunity
-
批准号:10092084
-
项目类别:
-
资助金额:$76.19万
-
财政年份:2018
-
负责人:James A Hoxie
-
依托单位:
Non-CD4 tropic SIV: Enhancing CD4 T-cell help in antiviral immune responses
-
批准号:8732145
-
项目类别:
-
资助金额:$84.23万
-
财政年份:2014
-
负责人:James A Hoxie
-
依托单位:
CONTROL OF AN SIVMAC239 TRANSMEMBRANE MUTANT IN PIGTAIL MACAQUES
-
批准号:8358143
-
项目类别:
-
资助金额:$5.78万
-
财政年份:2011
-
负责人:James A Hoxie
-
依托单位:
PATHOGENESIS OF AN ATTENUATED SIVMAC239 IN RHESUS AND PIGTAIL MACAQUES
-
批准号:8358095
-
项目类别:
-
资助金额:$5.78万
-
财政年份:2011
-
负责人:James A Hoxie
-
依托单位:
Optimizing HIV Env immuogens for T and B cell vaccine responses
-
批准号:8505364
-
项目类别:
-
资助金额:$51.77万
-
财政年份:2010
-
负责人:James A Hoxie
-
依托单位:
Optimizing HIV Env immuogens for T and B cell vaccine responses
-
批准号:8091276
-
项目类别:
-
资助金额:$65.41万
-
财政年份:2010
-
负责人:James A Hoxie
-
依托单位:
Optimizing HIV Env immuogens for T and B cell vaccine responses
-
批准号:7988637
-
项目类别:
-
资助金额:$58.7万
-
财政年份:2010
-
负责人:James A Hoxie
-
依托单位:
Optimizing HIV Env immuogens for T and B cell vaccine responses
-
批准号:8300199
-
项目类别:
-
资助金额:$55.19万
-
财政年份:2010
-
负责人:James A Hoxie
-
依托单位:
PATHOGENIC DETERMINANTS OF THE SIV ENVELOPE TRANSMEMBRANE CYTOPLASMIC DOMAIN
-
批准号:8173001
-
项目类别:
-
资助金额:$6.18万
-
财政年份:2010
-
负责人:James A Hoxie
-
依托单位:
PATHOGENIC DETERMINANTS OF THE SIV ENVELOPE TRANSMEMBRANE CYTOPLASMIC DOMAIN
-
批准号:7958683
-
项目类别:
-
资助金额:$6.27万
-
财政年份:2009
-
负责人:James A Hoxie
-
依托单位:
Pilot Projects
-
批准号:7981648
-
项目类别:
-
资助金额:$24.67万
-
财政年份:2009
-
负责人:James A Hoxie
-
依托单位:
Administrative
-
批准号:7684965
-
项目类别:
-
资助金额:$29.47万
-
财政年份:2009
-
负责人:James A Hoxie
-
依托单位:
PATHOGENESIS OF AN X4-TROPIC VARIANT OF SIVMAC239
-
批准号:7958703
-
项目类别:
-
资助金额:$5.81万
-
财政年份:2009
-
负责人:James A Hoxie
-
依托单位:
Pathogenic determinants of the SIV envelope transmembrane cytoplasmic domain
-
批准号:8471046
-
项目类别:
-
资助金额:$95.15万
-
财政年份:2008
-
负责人:James A Hoxie
-
依托单位:
Pathogenic determinants of the SIV envelope transmembrane cytoplasmic domain
-
批准号:8847629
-
项目类别:
-
资助金额:$79.52万
-
财政年份:2008
-
负责人:James A Hoxie
-
依托单位:
Pathogenic determinants of the SIV envelope transmembrane cytoplasmic domain
-
批准号:7579899
-
项目类别:
-
资助金额:$94.16万
-
财政年份:2008
-
负责人:James A Hoxie
-
依托单位:
Pathogenic determinants of the SIV envelope transmembrane cytoplasmic domain
-
批准号:8279208
-
项目类别:
-
资助金额:$81.37万
-
财政年份:2008
-
负责人:James A Hoxie
-
依托单位:
Administrative Core
-
批准号:7699957
-
项目类别:
-
资助金额:$25.96万
-
财政年份:2008
-
负责人:James A Hoxie
-
依托单位:
海外基金